|
|
|
Wireless
Medical Devices |
| |
Telecom Veteran Fran
Dramis and Hospitality Exec / Diabetes Advocate Dave Johnson
Round Out Diabetech® Advisory Board
Other Topics: Medical
Informatics Mobile Monitoring Solutions,
Wireless Medical Devices
PRWeb
April 16, 2007
Former BellSouth Corporation CIO Fran Dramis and JDRF
Executive Committee Member Dave Johnson Bring Knowledge &
Experience to the Leading Provider of Wireless Medical Devices,
Medical Informatics and Diabetes Social Networks
Dallas, TX -- Diabetech, LP, a proven leader and pioneer in
active disease management, today announced that Fran Dramis,
former Chief Information Officer for BellSouth Corporation (now
AT&T), has joined the Diabetech Advisory Board. Mr. Dramis is a
telecom industry veteran who brings to Diabetech vast knowledge
and experience, having designed, built, and managed some of the
largest, most complex, and secure service provider
infrastructure in the world.
Mr. Dramis joined BellSouth Corporation in 1998 as CIO and led
the IT organization as Chief Information, E-Commerce and
Security Officer for the past eight years. Before joining
BellSouth, Mr. Dramis worked with CIO Strategy, Inc., an
information technology consulting firm. Prior to that time, Mr.
Dramis was managing director and CIO at Salomon Brothers. Mr.
Dramis also served as president and chief executive officer of
Network Management and president and chief operating officer of
Telic Corporation. Early in his career, Mr. Dramis worked with
AT&T, including Bell Labs, rising to the position of executive
director of information product management. In addition to
serving on Diabetech's Advisory Board, Mr. Dramis currently
serves on the Boards of RealOps, Avocent Corporation and
webMethods. |
| |
|
|
| |
"We're very
excited to work with Fran as we develop our employer focused
interventional programs," said Kevin McMahon, President & CEO of
Diabetech. "Fran clearly understands the potential of technology
and appreciates our participant-centric system for delivering
just-in-time education with a unique design for enabling team
management including support from friends, family, co-workers
and their medical team. His first hand experience with this
innovative approach will help us to communicate with employers
struggling to control health care costs and for their employees,
dependents and retirees looking for an innovative program that
works."
Fran has been recognized by a variety of publications as a top
CIO and IT leader. "As a former CIO, I have witnessed
Diabetech's automated diabetes intervention programs in action.
By integrating real-time wireless medical devices, rules based
decision support and social networks, the long promised yet
seldom delivered return on investment from disease management
programs is here."
Dave Johnson, President & CEO of Aimbridge Hospitality and a
Executive Committee Member of Juvenile Diabetes Research
Foundation (JDRF) International brings a combination of business
savvy and diabetes-specific insight to the Diabetech Advisory
Board. In recent years, Mr. Johnson has helped Aimbridge to
become one of the fastest growing hotel management companies in
the United States. At the same time, his leadership within JDRF
has contributed to the launch of an exciting new track of
research focused on the development of an artificial pancreas; a
field of research that combines continuous glucose monitoring
intelligent insulin dosing through software designed to mimic
the body's own metabolic processes.
"My efforts in diabetes are focused on accelerating
'time-to-patient' for innovative cure therapies that mitigate
complications for our kids. As the father of a teen with type 1
diabetes, my family has experienced tremendous benefit from use
of the Diabetech technology inside of monitored research trials.
This is an exciting time for me and for Diabetech as we prepare
to make the GlucoMON® wireless glucose meter more accessible to
more families looking to simplify the way they manage diabetes",
said Johnson.
Before joining Aimbridge, Johnson spent 17 successful years with
Wyndham Hotels and Resorts helping them grow from ten hotels to
over 200. While at Wyndham, Johnson served as Executive Vice
President, President/Chief Marketing Officer, and President of
the Hotel Division. Johnson currently serves on several Boards
of Directors in addition to JDRF including Meeting Professionals
International and Active International. He is on the Board of
Governors for the University of North Texas and is a member in
good standing of the Chief Executive Round Table (CERT). Johnson
was most recently named to Starwood's Real Estate Development
Advisory Board. In 2003, he was named as one of the 25 Most
Extraordinary Minds in Hospitality Sales & Marketing by HSMAE.
"We're very excited to welcome Dave into the Diabetech family,"
said McMahon. "His insight and passion for improving the lives
of people with diabetes and those who care for them will help us
as we prepare to commercialize the GlucoMON later this year. In
addition to making sure that families understand the benefits
offered by Diabetech, delivering the 'five-star' customer
experience will be key to our success."
Other members of the Diabetech Advisory Board representing the
medical perspective include Stephen Ponder, MD CDE (pediatric
endocrinologist), Barbara Anderson, PhD (diabetes specific
behavioral scientist) and Barry Goldstein, MD PhD (adult
endocrinologist).
About Diabetech
Diabetech evaluates the opportunity to add wireless
connectivity, remote device management and field support for the
many medical device manufacturers and researchers years ahead of
the various emerging standards organizations. In early 2003,
Diabetech became the founding member behind Diabet-ML, an open
standard for diabetes relevant data integration. Unlike generic
wireless network aggregators and cellular device manufacturers,
Diabetech applies its intricate knowledge of the wireless
networks, the medical device industry and diabetes to seamlessly
integrate the design and manufacturing processes as well as
making sure that the people depending on this system enjoy
simplicity through automation and world class support.
Our wireless medical device certification program offers a
turnkey path for transforming disconnected medical devices into
favourable outcome generators. Due to significant investment in
our wireless data service provider platform, new wireless
handheld medical devices can be designed and deployed with
patients in the field in weeks without the high cost and delays
that go with one-off multi-vendor projects offered elsewhere.
Once devices are deployed, feasibility testing and design
optimization can be rapidly and cost-effectively performed at a
fraction of the cost of any other wireless service provider
including 510(k) submission and large scale commercialization of
these hybrid devices.
We push the limits of clinical informatics in the delivery of
real-world diabetes care. For more information on the company
and to participate in our version of proactive care, please
visit www.diabetech.net or call us toll free at 877.My.Gluco.
Interested parties outside of the US should send email to e-mail
protected from spam bots to initiate correspondence.
Diabetech and GlucoMON are registered trademarks of Diabetech,
LP.
GlucoMON is an investigational device subject to certain FDA
guidelines including 510(k) marketing clearance prior to
marketing for sale in the US. All other local regulations apply.
The performance characteristics of these devices have not been
established. This service offering is compliant with applicable
federal and state regulations including HIPAA, which govern the
privacy and security of human subjects research. |
| |
|
|
| |
|
|
